| Robert P Viles, MD | |
|
60 Crestwood Cir, Sugar Land, TX 77478-3914 | |
| (713) 302-0085 | |
| Not Available |
| Full Name | Robert P Viles |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 60 Crestwood Cir, Sugar Land, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053538900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D9699 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert P Viles, MD 60 Crestwood Cir, Sugar Land, TX 77478-3914 Ph: () - | Robert P Viles, MD 60 Crestwood Cir, Sugar Land, TX 77478-3914 Ph: (713) 302-0085 |
News Archive
Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
In the 40 years between 1970-2010, the proportion of patients with diabetes undergoing coronary artery bypass grafting (CABG) escalated from 7% to 37%. The results of a large study from Cleveland Clinic just published in The Journal of Thoracic and Cardiovascular Surgery, the official publication of the American Association for Thoracic Surgery, documents the five-fold increase in the proportion of patients with diabetes undergoing this procedure between 1970 and 2010.
A project spearheaded by a researcher at the University of Ottawa's Faculty of Medicine has been awarded $9 million in Canadian Institutes of Health Research (CIHR) funding to create a national network for better researching and responding to the global threat COVID-19 variants pose.
Protalex, Inc, a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and inflammatory diseases, today announced enrollment of the first patients in the 3rd cohort of its ongoing multicenter Phase 1b dose escalation clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA) being conducted in South Africa. The dose was increased by a factor of two from the 2nd cohort.
› Verified 1 days ago
Diana M. Guerra, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16651 Southwest Fwy, Suite 450, Sugar Land, TX 77479 Phone: 281-276-0827 Fax: 281-275-0760 | |
Dr. Anvinh Nguyen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4811 Harvest Chase Ln, Sugar Land, TX 77479 Phone: 832-618-5995 | |
Dr. Dawnna Marie Walton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 15591 Creek Bend Dr Ste 101, Sugar Land, TX 77478 Phone: 281-727-0076 | |
Dr. Amer A. Quaddoura, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1429 Highway 6 South, Sugar Land, TX 77478 Phone: 713-781-4600 Fax: 713-917-5780 | |
Oluwole E Oladute, M.D., PH.D., Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 306 Lakeglen Ct, Sugar Land, TX 77478 Phone: 281-238-5480 Fax: 832-595-9796 | |
Dr. Irfan Lalani, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy, Medical Office Building 3 Suite 320, Sugar Land, TX 77479 Phone: 281-265-0225 Fax: 281-265-2219 |